GH

Guardant Health
NASDAQ
96.71
+1.01
+1.06%
After Hours: 96.71 0 0.00% 16:10 05/11 EDT
OPEN
95.95
PREV CLOSE
95.70
HIGH
97.54
LOW
94.47
VOLUME
2.03M
TURNOVER
--
52 WEEK HIGH
120.74
52 WEEK LOW
36.36
MARKET CAP
12.82B
P/E (TTM)
-28.4433
1D
5D
1M
3M
1Y
5Y
1D
BTIG Reaffirms Their Buy Rating on Guardant Health (GH)
TipRanks · 1d ago
Guardant Health (GH) Earnings Spotlight Revenue Growth Versus Persistent Losses Challenges Premium Valuation Narratives
Simply Wall St · 2d ago
Guardant Health Earnings Call Highlights Breakout Growth
TipRanks · 2d ago
Guardant Health (GH) Q1 2026 Earnings Transcript
The Motley Fool · 3d ago
Guardant Health price target raised to $95 from $90 at Evercore ISI
TipRanks · 3d ago
Guardant Health Is Maintained at Overweight by JP Morgan
Dow Jones · 3d ago
Guardant Health Price Target Raised to $135.00/Share From $130.00 by JP Morgan
Dow Jones · 3d ago
JP Morgan Maintains Overweight on Guardant Health, Raises Price Target to $135
Benzinga · 3d ago
More
About GH
Guardant Health, Inc. is a precision oncology company focused on guarding wellness and giving every person more time free from cancer. It provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx test, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. It offers other tests, including Guardant360 Tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.

Webull offers Guardant Health Inc stock information, including NASDAQ: GH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GH stock methods without spending real money on the virtual paper trading platform.